MAIN ALAN J 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
MAIN ALAN J
EVP, Pharmaceutical Research
Transactions
- Exercise/Conversion
Common Stock
2025-02-28+25,667→ 281,391 total - Exercise/Conversion
Common Stock
2025-02-28+68,243→ 382,538 total - Tax Payment
Common Stock
2025-02-28$0.67/sh−43,434$29,101→ 339,104 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−25,667→ 0 total→ Common Stock (25,667 underlying) - Exercise/Conversion
Common Stock
2025-02-28+32,904→ 314,295 total - Exercise/Conversion
Restricted Stock Units
2025-02-28−32,904→ 32,903 total→ Common Stock (32,904 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-28−68,243→ 136,487 total→ Common Stock (68,243 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.